Verified Nov 2026
Batteries & E-Mobility
·

Bengaluru, Karnataka
·
Since 1993
Syngene International Limited is a contract research, development, and manufacturing organization headquartered in Bengaluru, India, founded in 1993. The company employs 5,000–10,000 people and generates estimated revenue of $250–500M. A subsidiary of Biocon Limited, Syngene serves pharmaceutical, biotechnology, agrochemical, and related industries across drug discovery, development, and manufacturing. The company extended a strategic collaboration with Bristol Myers Squibb through 2035 and opened a biologics facility in the U.S.
Syngene International Limited at a glance
Revenue
$250-500M
Est. band
Employees
5,000-10,000
Founded
1993
Headquarters
Bengaluru, Karnataka
Certifications
ISO 14001 · ISO 45001
Industries
Automotive
Electric Vehicles
Medical
Renewable Energy
Industrial Equipment
Consumer Goods
STABILITY SIGNALS
Established & active
33 years in operation (founded 1993).
Holds ISO 14001, ISO 45001 certification(s) per public sources.
Overview
Syngene International Limited is a contract research, development, and manufacturing organization headquartered in Bengaluru, India, founded in 1993. The company employs 5,000–10,000 people and generates estimated revenue of $250–500M. A subsidiary of Biocon Limited, Syngene serves pharmaceutical, biotechnology, agrochemical, and related industries across drug discovery, development, and manufacturing. The company extended a strategic collaboration with Bristol Myers Squibb through 2035 and opened a biologics facility in the U.S.
At a glance
Attribute | Detail |
|---|---|
Founded | 1993 |
Headquarters | Bengaluru, Karnataka |
Employees | 5,000-10,000 |
Revenue | $250-500M (estimated) |
Primary capability | Batteries & E-Mobility |
Certifications | ISO 14001 · ISO 45001 |
What Syngene International Limited makes
The company provides drug discovery and development, clinical trial management, and cGMP-compliant commercial manufacturing, with capabilities spanning small molecules, biologics, peptides, oligonucleotides, and antibody-drug conjugates.
Certifications
Syngene International Limited is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:
ISO 14001 — syngeneintl.com
ISO 45001 — syngeneintl.com
Latest developments
2026-08-24 — Syngene International invests ₹2.52 crore in Ampin C&I Power Twelve for renewable power acquisition · Business Upturn (businessupturn.com)
2026-01-20 — Bristol Myers Squibb, Syngene extend strategic collaboration through 2035 | Pharma Manufacturing (pharmamanufacturing.com)
2025-12-03 — Syngene's new biologics facility in the U.S. - Syngene International Ltd (syngeneintl.com)
2025-11-09 — Syngene eyes growth tailwinds from global trial wins, biotech funding recovery: CEO - The HinduBusinessLine (thehindubusinessline.com)
2025-10-27 — Syngene International announces plans to add bioconjugation suite for end-to-end Antibody-Drug Conjugates Development (prnewswire.com)
2025-10-23 — Syngene International confirms expansion of biologics facility with new ADC bioconjugation capability - CNBC TV18 (cnbctv18.com)
Facilities
Syngene International Limited is headquartered in Bengaluru, Karnataka. Public sources also reference these locations:
Bayview, Maryland — syngeneintl.com
Bengaluru, India — pharmamanufacturing.com
Company details
Syngene operates over 2.2 million square feet of research and development facilities and serves more than 400 global customers, including multinational corporations. Syngene International Limited was founded in 1993, has an estimated 5,000-10,000 employees, and is headquartered in Bengaluru, Karnataka. On the LightSource stability read it is rated "Established & active": 33 years in operation (founded 1993). Holds ISO 14001, ISO 45001 certification(s) per public sources.
Frequently asked questions
What does Syngene International Limited make?
Syngene International Limited is a contract research, development, and manufacturing organization headquartered in Bengaluru, India, founded in 1993. The company employs 5,000–10,000 people and generates estimated revenue of $250–500M. A subsidiary of Biocon Limited, Syngene serves pharmaceutical, biotechnology, agrochemical, and related industries across drug discovery, development, and manufacturing. The company extended a strategic collaboration with Bristol Myers Squibb through 2035 and opened a biologics facility in the U.S.
Where is Syngene International Limited headquartered?
Syngene International Limited is headquartered in Bengaluru, Karnataka (Hosur Road, Bengaluru, Karnataka).
When was Syngene International Limited founded?
Syngene International Limited was founded in 1993.
How big is Syngene International Limited?
Syngene International Limited has an estimated 5,000-10,000 employees, with revenue in the $250-500M range (estimated).
What certifications does Syngene International Limited hold?
Syngene International Limited lists ISO 14001 · ISO 45001 on its website. Confirm the certified scope for the specific plant producing your part.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
